If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...

Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of ...

Targeting IL-18BP to Boost Immunity. Graphical Abstract ©ArnaudHUARD/UNIGE. SUMMARY. Interleukin (IL)-18 is an immunoregulatory cytokine that acts as a potent inducer of T helper ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...

Scientists from the National Institutes of Health on Monday said several mosquito-borne viruses are circulating in Montana, ...

Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class pseudo-resistance-targeting agent, PenetriumTM, showed significant anti-metastatic efficacy in a preclinical study ...

An Aerosol Test for Airborne ... previously unrecognized class of antibodies -- immune system proteins that protect against disease -- that appear capable of neutralizing multiple forms of flu ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...